Influence
December 17, 2024

Regenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers

Sarah Wiehe, MD

A paper co-authored by Regenstrief Research Scientist Sarah Wiehe, M.D., M.P.H., as a member of the U.S. Preventive Services Task Force (USPSTF), is one of 2024’s most viewed papers from the well-respected Journal of the American Medical Association (JAMA).  

The article, “Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement,” was among the top 10 for 2024 and was announced on Tuesday, December 17, 2024.The updated guidelines emphasize the importance of biennial mammography screening for women aged 40 to 74 years to reduce breast cancer-related deaths. 

Breast cancer remains the second most common cancer and cause of cancer death among women in the United States. The new recommendations suggest starting regular mammography screenings at age 40 to achieve a moderate net benefit in reducing breast cancer mortality. 

Dr. Wiehe was appointed to serve a four-year term on the task force in January of 2024. Task force members are appointed by the secretary of Health and Human Services. 

On the task force, Dr. Wiehe works to improve the health of people nationwide by making evidence-based recommendations about clinical preventive services. Because the task force is an independent, volunteer panel of national experts in prevention and evidence-based medicine, they are equipped to suggest services such as screenings, counseling services and preventive medications. 

The task force’s updated recommendation is a shift that prioritizes earlier screening, particularly given breast cancer’s continued impact across diverse populations. Non-Hispanic Black women, who experience the highest breast cancer mortality rate, stand to benefit from efforts to improve access to and adherence to recommended screenings. 

Sarah Wiehe, M.D., MPH  

In addition to her role as a research scientist with the William M. Tierney Center for Health Services Research at Regenstrief Institute, Sarah Wiehe, M.D., MPH, is the co-director of the Indiana Clinical and Translational Sciences Institute. She is a professor of pediatrics, associate dean for community and translational research, the Jean and Jerry Bepko Scholar in Pediatrics, and the chief of the Division of Children’s Health Services Research at Indiana University School of Medicine. Dr. Wiehe is also an adjust associate professor at the Indiana Richard M. Fairbanks School of Public Health at IU Indianapolis. 

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher